Therapeutic Drug Monitoring (TDM) of biologics entails measuring drug and anti-drug antibody concentrations, with subsequent possible dose adjustment to ensure optimised dosing for the patient.
Products are for professional/laboratory use only.
Explore the new range of Theradiag IMMUNO-TROL FEIA – a complete range of third-party Quality Controls specifically designed for use with Phadia EliA assays. IMMUNO-TROL FEIA is suitable for use on the Thermo Fisher Phadia range of systems – Phadia 250, Phadia 2500E/EE, Phadia 200.
Products are for professional/laboratory use only.
Abacus dx are pleased to present this poster from Theradiag on the performance of the new and innovative i-Tracker infliximab and anti-infliximab assays for use in Therapeutic Drug Monitoring (TDM)
Products are for professional/laboratory use only.
Abacus dx is pleased to launch Theradiag i-Tracker on the IDS iSYS – the first fully automated, random-access platform for Therapeutic Drug Monitoring (TDM).
Products are for professional/laboratory use only.
Swapping versus dose optimization in patients losing response to adalimumab with adequate drug levels. Roblin X, Genin C, Nancey S, Williet N, Veyrard P, Boschetti G, Phelip JM, Berger AE, Killian M, Waeckel L, Flourie B and Paul S. Inflammatory Bowel Diseases, 2021, Aug 18:izab158.
Products are for professional/laboratory use only.
TDM in Chronic Inflammatory Diseases (CID)
Biologic therapies, and notably Monoclonal antibodies (mAbs) and Fusion Proteins (FP), have revolutionised the management of CID, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Psoriatic Arthritis that affect millions of people worldwide.
Products are for professional/laboratory use only. With the evolution of COVID-19, Theradiag is committed to providing the medical community with the necessary products to aid in the COVID-19 response.
Products are for professional/laboratory use only.
Please find below a summary of the recently published British guidelines on the management of inflammatory bowel disease in adults.
Products are for professional/laboratory use only.
Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease. Painchart C, Brabant S et al; Dig Dis Sci. 2019 Oct 10.